Clinical trial

Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation

NCT01729676

Study summary

ClinicalTrials.gov

Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Degarelix or GnRH agonist Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2013-05-01

PhaseN/A

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

Degarelix or GnRH agonistDRUG

Sponsors & collaborators

Ferring Pharmaceuticalslead sponsor

Mapped research locations

LibourneFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01729676 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.